PharmaBoardroom

Interview with Stavros Nicolaou, Chairman, PHARMISA South Africa

South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac…

Interview with John Norman, Country Manager, Nycomed South Africa

Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in…

Interview with Michael Azrak, Managing Director, MSD South Africa

If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…

Interview with Laura Engelbrecht Joubert, General Manager –…

Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations…

Stephen Saad, Group Chief Executive, Aspen

The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years…

Interview with Patrick Godard, Chief Executive Officer, Amayeza…

Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It…

Interview with John D Hallam, Chairman, Abex Pharmaceutica

Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a…

Interview with Ann-Marie Hosang-Archer, Managing Director SA…

You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South…

Interview with Joong Keun Cha, President & CEO, Yuhan

Yuhan is one of the largest and fastest growing pharmaceutical companies in South Korea, with a long history in the sector. In your view, what are the…

Interview with WonJung Choi, President, Dream CIS

South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea's…

Interview with Zdeněk Zahradník, General Manager, Teva Czech…

Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical…

Interview with Richard de Chastelain, Country Division Head,…

Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare…

Tagged with